This study investigated the behavioural and
anticonvulsant effects of voltage-sensitive
calcium channel blockers in DBA/2 mice.
Omega-Conotoxin MVIIC (0.1, 0.3 micrograms ICV/mouse) and
omega-agatoxin IVA (0.1, 0.3, 1 micrograms ICV), which act predominantly at P- and/or
Q-type calcium channels, prevented clonic and tonic sound-induced
seizures in this animal model of
reflex epilepsy (ED50 values with 95% confidence limits for protection against clonic sound-induced
seizures were 0.09 (0.04-0.36) micrograms ICV and 0.09 (0.05-0.15) micrograms ICV respectively and against
tonic seizures 0.07 (0.03-0.16) micrograms ICV and 0.08 (0.04-0.13) micrograms ICV, respectively). The
N-type calcium channel antagonists
omega-conotoxin GVIA and
omega-conotoxin MVIIA were also tested in this model.
Omega-Conotoxin GVIA was
anticonvulsant in DBA/2 mice, but only at high doses (3 micrograms ICV prevented
tonic seizures in 60% of the animals; 10 micrograms ICV prevented
clonic seizures in 60% and
tonic seizures in 90% of the animals), whereas
omega-conotoxin MVIIA did not inhibit sound-induced
seizures in doses up to 10 micrograms ICV. Both
omega-conotoxin GVIA and
omega-conotoxin MVIIA induced an intense shaking syndrome in doses as low as 0.1 microgram ICV, whereas
omega-conotoxin MVIIC and
omega-agatoxin IVA did not produce shaking at any of the doses examined. Finally,
omega-conotoxin GI (0.01-1 microgram ICV) and
alpha-conotoxin SI (0.3-30 micrograms ICV), which both act at
acetylcholine nicotinic receptors, were not
anticonvulsant and did not induce shaking in DBA/2 mice. These results confirm that blockers of N- and P-/
Q-type calcium channels produce different behavioural responses in animals. The
anticonvulsant effects of
omega-conotoxin MVIIC and
omega-agatoxin IVA in DBA/2 mice are consistent with reports that P- and/or
Q-type calcium channel blockers inhibit the release of
excitatory amino acids and are worthy of further exploration.